Potential Challenges of Molecular Testing in NSCLC
June 3rd 2021A panel of experts in the management of lung cancer share key insights into challenges associated with retesting for driver mutations, tumor heterogeneity, and potential differences between biopsy and surgical sample test results.
Read More